https://pacylex.com/news https://pacylex.com/resources https://pacylex.com https://pacylex.com/team https://pacylex.com/contact https://pacylex.com/post/2022aacr https://pacylex.com/post/acute-myeloid-leukemia-at-the-world-orphan-drug-congress https://pacylex.com/post/ash-2022 https://pacylex.com/post/bio-and-faseb-conferences https://pacylex.com/post/biotech-showcase-2023 https://pacylex.com/post/closes-series-a https://pacylex.com/post/fda-clearance-aml https://pacylex.com/post/fierce-biotech-covers-pacylex-pharmaceuticals-recent-progress https://pacylex.com/post/first-clinical-experience-with-an-n-myristoyltransferase-nmt-inhibitor-in-a-patient-published https://pacylex.com/post/first-patient-dosed-in-a-phase-2a-study-of-zelenirstat-in-patients-with-refractory-metastatic-colorectal-cancer https://pacylex.com/post/grand-opening-of-merck-accelerator-in-edmonton-pacylex-one-of-first-4-companies-accepted https://pacylex.com/post/leap-magazine-names-pacylex-cso-as-a-rockstar-scientist https://pacylex.com/post/major-grant-awarded-to-study-pclx-001-in-acute-myeloid-leukemia-patients https://pacylex.com/post/major-milestones-in-2023-set-the-stage-for-series-b-funding https://pacylex.com/post/new-data-on-moa https://pacylex.com/post/orphan-drug-designation-acute-myeloid-leukemia https://pacylex.com/post/pacylex-and-zelenirstat-featured-in-global-news https://pacylex.com/post/pacylex-announces-full-slate-of-fall-presentations https://pacylex.com/post/pacylex-ceo https://pacylex.com/post/pacylex-ceo-michael-weickert-interviewed-for-ceo-cfo-magazine https://pacylex.com/post/pacylex-featured-as-one-of-canadas-10-most-valuable-healthcare-solution-providers-by-insightscare https://pacylex.com/post/pacylex-featured-on-biotech-nation-with-dr-moira-gunn https://pacylex.com/post/pacylex-granted-fda-fast-track-designation https://pacylex.com/post/pacylex-interviewed-at-the-bio-investor-forum https://pacylex.com/post/pacylex-joins-creative-destruction-labs-2019-20-health-cohort https://pacylex.com/post/pacylex-listed-as-one-of-the-10-best-healthcare-companies-to-watch https://pacylex.com/post/pacylex-pharmaceuticals-announces-first-patient-dosed-in-a-phase-2a-study-of-pclx-001-in-patients-with-relapsed-refractory-non-hodgkin-lymphoma https://pacylex.com/post/pacylex-pharmaceuticals-announces-new-executive-team-members-as-the-company-accelerates-clinical-development-of-pclx-001 https://pacylex.com/post/pacylex-pharmaceuticals-announces-progress-on-early-phase-clinical-trials-of-pclx-001-in-patients https://pacylex.com/post/pacylex-pharmaceuticals-announces-publication-in-nature-communications-of-a-new-target-for-therapeutic-intervention-in-hematologic-malignancies-and-preclinical-results-of-a-first-in-class-therapy https://pacylex.com/post/pacylex-pharmaceuticals-reports-a-potential-drug-sensitivity-gene-signature-and-the-effects-of-myristoylation-inhibition-on-angiogenesis-and-cancer-cell-migration-at-american-association-of-cancer-research-aacr-2023 https://pacylex.com/post/pacylex-presented-initial-clinical-experience-with-pclx-001-in-patients-at-ash-2021 https://pacylex.com/post/pacylex-presents-as-medical-and-investment-conferences-go-virtual https://pacylex.com/post/pacylex-presents-at-2019-biotech-showcase https://pacylex.com/post/pacylex-raises-us-3-9-million-to-advance-new-cancer-therapy-pclx-001-towards-clinical-trials https://pacylex.com/post/pacylex-to-meet-with-investors-at-bio-ceo-conference-bcic-in-new-york https://pacylex.com/post/phase-1-clinical https://pacylex.com/post/phase-1-safety-and-efficacy-results-for-zelenirstat-in-colorectal-and-other-cancers https://pacylex.com/post/phase-i https://pacylex.com/post/phase-i-clinical-experience-interview-with-pacylex-ceo https://pacylex.com/post/publication-in-breast-cancer-research-and-treatment https://pacylex.com/post/safety-and-efficacy-results-phase-1 https://pacylex.com/post/sweet-biopharma-day-2023 https://pacylex.com/post/targeting-n-myristoyltransferases-in-cancer https://pacylex.com/post/two-pacylex-abstracts-accepted-for-presentation-at-the-american-association-for-cancer-research-aacr-conference https://pacylex.com/post/worlds-longest-baseball-game-raises-funds-for-pclx-001-development https://pacylex.com/post/zelenirstat-disrupts-oxidative-phosphorylation https://pacylex.com/post/zelenirstat-shows-potent-in-vitro-radiosensitization-in-human-glioblastoma-models